Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank21
3Y CAGR+5.0%
5Y CAGR-16.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+5.0%/yr
vs -14.8%/yr prior
5Y CAGR
-16.8%/yr
Recent acceleration
Acceleration
+19.8pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $61.12M | -27.7% |
| 2024 | $84.48M | +43.5% |
| 2023 | $58.89M | +11.5% |
| 2022 | $52.82M | -4.1% |
| 2021 | $55.05M | -64.2% |
| 2020 | $153.62M | +67.1% |
| 2019 | $91.92M | -8.3% |
| 2018 | $100.24M | -36.1% |
| 2017 | $156.81M | -12.0% |
| 2016 | $178.15M | - |